Thermo Fisher Scientific is experiencing a robust demand recovery, with Q2 2026 revenue growth accelerating to 10.5% and gross margin expanding to 41.2% from 37.3% a year earlier.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth accelerated to 10.5% in Q2 2026, with gross margin improving to 41.2% from 37.3% a year earlier, though it remains below peers like Danaher's 60.9%.
T-Mobile holds approximately 35% of the wireless market share and its Ultra Capacity 5G network reaches nearly 98% of the U.S. population.
Q1 2026 revenues reached $23.11 billion, marking an 11% year-over-year increase, with EPS at $2.27, exceeding forecasts.
The company expects to return up to $18.2 billion to stockholders in 2026 through share repurchases and dividends.
Rivals like Verizon and AT&T are heavily investing in their networks, which could pressure T-Mobile's market share and pricing.
There are worries about slowing postpaid phone net adds and potential increases in churn rates, particularly in smaller markets.
T-Mobile carries a significant debt load of $86.95 billion as of December 2025, increasing financial risk in a rising interest rate environment.
Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 21, 2026 | $6.68+4.4% vs $6.40 | $12.1B+1.5% vs $12.0B |
Q3 2026 Jul 23, 2026 | $6.03+5.4% vs $5.72 | $12.0B+2.5% vs $11.7B |
Q2 2026 Apr 23, 2026 | $5.44+3.6% vs $5.25 | $11.0B+1.3% vs $10.9B |
Q1 2026 Jan 29, 2026 | $6.57+1.9% vs $6.45 | $12.2B+2.2% vs $11.9B |
Thermo Fisher Scientific, Inc. (NYSE:TMO) shares are trading higher by about half a percent on Friday as the company authorized a new share repurchase program and risk appetite is firm, with S&P 500 futures up 1.2%.
The Fund returned 3.18% compared to a 2.61% return for the Russell 1000 Value Index. Key contributors include Microsoft, Salesforce and Thermo Fisher Scientific. Key detractors include Aon, Carrier Global and Builders FirstSource.
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of up to an aggregate of $5 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company's existing repurchase authorization, of which $1 billion was remaining. About Thermo Fisher Scientific Thermo Fisher Scientific.
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on January 15, 2027, to shareholders of record as of December 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world he.
Benchmark TMO against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Thermo Fisher Scientific Inc. (TMO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $694.76 | $258.19B | 36.39 | 3.91% | 14.96% | 13.3% | 0.24% | |
| $230.25 | $161.86B | 37.58 | 2.9% | 16.91% | 8.18% | 0.54% | |
| $174.76 | $49.36B | 34.35 | 6.73% | 19.53% | 20.47% | 0.57% | |
| $457.60 | $34.22B | 459.62 | 6.99% | 1.75% | 0.81% | — | |
| $381.57 | $10.27B | 10.05 | 0.65% | 39.45% | 14.07% | — | |
| $61.31 | $9.33B | -75.77 | 2.08% | -3.51% | -5.05% | 0.24% |
Thermo Fisher Scientific Inc. (TMO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Thermo Fisher Scientific Inc. (TMO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 30, 2026·SEC
Oct 21, 2026·SEC
Jul 23, 2026·SEC
Get notified when TMO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Thermo Fisher Scientific Inc. (TMO) stock FAQ — growth, dividends, profitability & financials explained
Thermo Fisher Scientific Inc. (TMO) reported $47.35B in revenue over the trailing twelve months. Revenue was $44.56B in fiscal year 2025. That is 1419% more than the $2.93B of fiscal year 1996.
Thermo Fisher Scientific Inc. (TMO) grew revenue by 8.3% over the trailing twelve months, compared with the twelve months before.
Yes. Thermo Fisher Scientific Inc. (TMO) earned $7.08B in net income over the trailing twelve months (a 15.0% net margin).
Yes. Thermo Fisher Scientific Inc. (TMO) pays a dividend that yields 0.24% at the current price, a small yield.
Thermo Fisher Scientific Inc. (TMO) had a return on equity (ROE) of 13.3% over the trailing twelve months. That is in line with the market's typical 10-15%.
Thermo Fisher Scientific Inc. (TMO) generated $7.60B in free cash flow over the trailing twelve months.
